Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125454271 | 12545427 | 1 | I | 201603 | 20160707 | 20160711 | 20160711 | EXP | FR-AFSSAPS-AM20160838 | FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-44655FF | BOEHRINGER INGELHEIM | 46.52 | YR | F | Y | 0.00000 | 20160711 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125454271 | 12545427 | 1 | PS | APTIVUS | TIPRANAVIR | 1 | Oral | STRENGTH: 250MG | 21814 | CAPSULE, SOFT | |||||||||
| 125454271 | 12545427 | 2 | SS | TIVICAY | DOLUTEGRAVIR SODIUM | 1 | Oral | 100 MG | 0 | 100 | MG | COATED TABLET | QD | ||||||
| 125454271 | 12545427 | 3 | SS | LAROXYL | AMITRIPTYLINE | 1 | Oral | 100 MG | 0 | 50 | MG | COATED TABLET | BID | ||||||
| 125454271 | 12545427 | 4 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG | 0 | 75 | MG | PROLONGED-RELEASE CAPSULE | BID | ||||||
| 125454271 | 12545427 | 5 | SS | NORVIR | RITONAVIR | 1 | Oral | 400 MG | 0 | 200 | MG | COATED TABLET | BID | ||||||
| 125454271 | 12545427 | 6 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | STRENGTH: 200 MG/245 MG; DOSE PER APPLICATION: 200 MG /245; DAILY DOSE: 200 MG /245; | 0 | COATED TABLET | QD | ||||||||
| 125454271 | 12545427 | 7 | SS | IMOVANE | ZOPICLONE | 1 | Oral | 7.5 MG | 0 | 7.5 | MG | COATED TABLET | QD | ||||||
| 125454271 | 12545427 | 8 | SS | THERALENE | TRIMEPRAZINE | 1 | Oral | STRENGTH: 5 MG | 0 | COATED TABLET | |||||||||
| 125454271 | 12545427 | 9 | SS | TERCIAN | CYAMEMAZINE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125454271 | 12545427 | 1 | Acquired immunodeficiency syndrome |
| 125454271 | 12545427 | 2 | Acquired immunodeficiency syndrome |
| 125454271 | 12545427 | 3 | Depression |
| 125454271 | 12545427 | 4 | Depression |
| 125454271 | 12545427 | 5 | Acquired immunodeficiency syndrome |
| 125454271 | 12545427 | 6 | Acquired immunodeficiency syndrome |
| 125454271 | 12545427 | 7 | Insomnia |
| 125454271 | 12545427 | 8 | Depression |
| 125454271 | 12545427 | 9 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125454271 | 12545427 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125454271 | 12545427 | Completed suicide | |
| 125454271 | 12545427 | Depression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125454271 | 12545427 | 1 | 2013 | 20160323 | 0 | |
| 125454271 | 12545427 | 2 | 20160314 | 20160323 | 0 | |
| 125454271 | 12545427 | 3 | 201511 | 20160323 | 0 | |
| 125454271 | 12545427 | 4 | 201504 | 20160323 | 0 | |
| 125454271 | 12545427 | 5 | 20160314 | 20160323 | 0 | |
| 125454271 | 12545427 | 6 | 20160314 | 20160323 | 0 | |
| 125454271 | 12545427 | 7 | 201504 | 20160323 | 0 | |
| 125454271 | 12545427 | 8 | 20160323 | 0 | ||
| 125454271 | 12545427 | 9 | 20160323 | 0 |